-
Je něco špatně v tomto záznamu ?
Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice
J Turanek, XF Wang, P Knotigova, S Koudelka, LF Dong, E Vrublova, E Mahdavian, L Prochazka, S Sangsura, A Vacek, BA Salvatore, J Neuzil
Jazyk angličtina Země Spojené státy americké
Typ dokumentu srovnávací studie, práce podpořená grantem
- MeSH
- alfa-tokoferol analogy a deriváty aplikace a dávkování farmakologie MeSH
- antitumorózní látky aplikace a dávkování farmakologie MeSH
- chemie farmaceutická MeSH
- lidé MeSH
- liposomy MeSH
- maleimidy aplikace a dávkování farmakologie MeSH
- melanom experimentální farmakoterapie patologie MeSH
- myši inbrední BALB C MeSH
- myši inbrední C57BL MeSH
- myši transgenní MeSH
- myši MeSH
- nádorové buněčné linie MeSH
- nádory prsu farmakoterapie patologie MeSH
- polyethylenglykoly aplikace a dávkování farmakologie MeSH
- vitamin E analogy a deriváty aplikace a dávkování farmakologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
- srovnávací studie MeSH
The vitamin E analogue alpha-tocopheryl succinate (alpha-TOS) is an efficient anti-cancer drug. Improved efficacy was achieved through the synthesis of alpha-tocopheryl maleamide (alpha-TAM), an esterase-resistant analogue of alpha-tocopheryl maleate. In vitro tests demonstrated significantly higher cytotoxicity of alpha-TAM towards cancer cells (MCF-7, B16F10) compared to alpha-TOS and other analogues prone to esterase-catalyzed hydrolysis. However, in vitro models demonstrated that alpha-TAM was cytotoxic to non-malignant cells (e.g. lymphocytes and bone marrow progenitors). Thus we developed lyophilized liposomal formulations of both alpha-TOS and alpha-TAM to solve the problem with cytotoxicity of free alpha-TAM (neurotoxicity and anaphylaxis), as well as the low solubility of both drugs. Remarkably, neither acute toxicity nor immunotoxicity implicated by in vitro tests was detected in vivo after application of liposomal alpha-TAM, which significantly reduced the growth of cancer cells in hollow fiber implants. Moreover, liposomal formulation of alpha-TAM and alpha-TOS each prevented the growth of tumours in transgenic FVB/N c-neu mice bearing spontaneous breast carcinomas. Liposomal formulation of alpha-TAM demonstrated anti-cancer activity at levels 10-fold lower than those of alpha-TOS. Thus, the liposomal formulation of alpha-TAM preserved its strong anti-cancer efficacy while eliminating the in vivo toxicity found of the free drug applied in DMSO. Liposome-based targeted delivery systems for analogues of vitamin E are of interest for further development of efficient and safe drug formulations for clinical trials.
- 000
- 04227naa 2200649 a 4500
- 001
- bmc11009333
- 003
- CZ-PrNML
- 005
- 20121114110548.0
- 008
- 110509s2009 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Turánek, Jaroslav $7 xx0118573
- 245 10
- $a Liposomal formulation of alpha-tocopheryl maleamide: in vitro and in vivo toxicological profile and anticancer effect against spontaneous breast carcinomas in mice / $c J Turanek, XF Wang, P Knotigova, S Koudelka, LF Dong, E Vrublova, E Mahdavian, L Prochazka, S Sangsura, A Vacek, BA Salvatore, J Neuzil
- 314 __
- $a Department of Vaccinology and Immunotherapy, Veterinary Research Institute, Brno, Czech Republic. turanek@vri.cz
- 520 9_
- $a The vitamin E analogue alpha-tocopheryl succinate (alpha-TOS) is an efficient anti-cancer drug. Improved efficacy was achieved through the synthesis of alpha-tocopheryl maleamide (alpha-TAM), an esterase-resistant analogue of alpha-tocopheryl maleate. In vitro tests demonstrated significantly higher cytotoxicity of alpha-TAM towards cancer cells (MCF-7, B16F10) compared to alpha-TOS and other analogues prone to esterase-catalyzed hydrolysis. However, in vitro models demonstrated that alpha-TAM was cytotoxic to non-malignant cells (e.g. lymphocytes and bone marrow progenitors). Thus we developed lyophilized liposomal formulations of both alpha-TOS and alpha-TAM to solve the problem with cytotoxicity of free alpha-TAM (neurotoxicity and anaphylaxis), as well as the low solubility of both drugs. Remarkably, neither acute toxicity nor immunotoxicity implicated by in vitro tests was detected in vivo after application of liposomal alpha-TAM, which significantly reduced the growth of cancer cells in hollow fiber implants. Moreover, liposomal formulation of alpha-TAM and alpha-TOS each prevented the growth of tumours in transgenic FVB/N c-neu mice bearing spontaneous breast carcinomas. Liposomal formulation of alpha-TAM demonstrated anti-cancer activity at levels 10-fold lower than those of alpha-TOS. Thus, the liposomal formulation of alpha-TAM preserved its strong anti-cancer efficacy while eliminating the in vivo toxicity found of the free drug applied in DMSO. Liposome-based targeted delivery systems for analogues of vitamin E are of interest for further development of efficient and safe drug formulations for clinical trials.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antitumorózní látky $x aplikace a dávkování $x farmakologie $7 D000970
- 650 _2
- $a nádory prsu $x farmakoterapie $x patologie $7 D001943
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a chemie farmaceutická $7 D002626
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a liposomy $7 D008081
- 650 _2
- $a maleimidy $x aplikace a dávkování $x farmakologie $7 D008301
- 650 _2
- $a melanom experimentální $x farmakoterapie $x patologie $7 D008546
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši transgenní $7 D008822
- 650 _2
- $a polyethylenglykoly $x aplikace a dávkování $x farmakologie $7 D011092
- 650 _2
- $a vitamin E $x analogy a deriváty $x aplikace a dávkování $x farmakologie $7 D014810
- 650 _2
- $a alfa-tokoferol $x analogy a deriváty $x aplikace a dávkování $x farmakologie $7 D024502
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Wang, Xiu-Fang
- 700 1_
- $a Turánek-Knötigová, Pavlína $7 xx0137875
- 700 1_
- $a Koudelka, Štěpán $7 xx0137876
- 700 1_
- $a Dong, Lan-Feng
- 700 1_
- $a Orolinová, Eva, $d 1983- $7 xx0120199
- 700 1_
- $a Mahdavian, Elahe
- 700 1_
- $a Procházka, Lubomír $7 xx0100254
- 700 1_
- $a Sangsura, Smink
- 700 1_
- $a Vacek, Antonín, $d 1929-2009 $7 jk01140948
- 700 1_
- $a Salvatore, Brian A.
- 700 1_
- $a Neužil, Jiří, $d 1958- $7 xx0115772
- 773 0_
- $t Toxicology & Applied Pharmacology $w MED00010691 $g Roč. 237, č. 3 (2009), s. 249-257
- 910 __
- $a ABA008 $b x $y 6
- 990 __
- $a 20110513104611 $b ABA008
- 991 __
- $a 20121114110604 $b ABA008
- 999 __
- $a ok $b bmc $g 838950 $s 702718
- BAS __
- $a 3
- BMC __
- $a 2009 $b 237 $c 3 $d 249-257 $m Toxicology and applied pharmacology $n Toxicol Appl Pharmacol $x MED00010691
- LZP __
- $a 2011-2B09/lmme